🎉 M&A multiples are live!
Check it out!

JFL Life Sciences Valuation Multiples

Discover revenue and EBITDA valuation multiples for JFL Life Sciences and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

JFL Life Sciences Overview

About JFL Life Sciences

JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.


Founded

2010

HQ

India
Employees

39

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$8.3M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

JFL Life Sciences Financials

JFL Life Sciences has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, JFL Life Sciences achieved revenue of $5.4M and an EBITDA of $0.6M.

JFL Life Sciences expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See JFL Life Sciences valuation multiples based on analyst estimates

JFL Life Sciences P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $5.0M $5.4M XXX XXX XXX
Gross Profit $0.9M $1.0M XXX XXX XXX
Gross Margin 18% 18% XXX XXX XXX
EBITDA $0.6M $0.6M XXX XXX XXX
EBITDA Margin 13% 11% XXX XXX XXX
Net Profit $0.3M $0.3M XXX XXX XXX
Net Margin 7% 6% XXX XXX XXX
Net Debt $1.8M $0.8M XXX XXX XXX

Financial data powered by Morningstar, Inc.

JFL Life Sciences Stock Performance

As of April 15, 2025, JFL Life Sciences's stock price is INR 20 (or $0).

JFL Life Sciences has current market cap of INR 662M (or $7.7M), and EV of INR 718M (or $8.3M).

See JFL Life Sciences trading valuation data

JFL Life Sciences Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$8.3M $7.7M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

JFL Life Sciences Valuation Multiples

As of April 15, 2025, JFL Life Sciences has market cap of $7.7M and EV of $8.3M.

JFL Life Sciences's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate JFL Life Sciences's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for JFL Life Sciences and 10K+ public comps

JFL Life Sciences Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $8.3M XXX XXX XXX
EV/Revenue 1.5x XXX XXX XXX
EV/EBITDA 14.4x XXX XXX XXX
P/E 20.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 31.8x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get JFL Life Sciences Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

JFL Life Sciences Valuation Multiples

JFL Life Sciences's NTM/LTM revenue growth is n/a

JFL Life Sciences's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $11K for the same period.

Over next 12 months, JFL Life Sciences's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate JFL Life Sciences's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for JFL Life Sciences and other 10K+ public comps

JFL Life Sciences Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 11% XXX XXX XXX XXX
EBITDA Growth -9% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $11K XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 8% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

JFL Life Sciences Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

JFL Life Sciences M&A and Investment Activity

JFL Life Sciences acquired  XXX companies to date.

Last acquisition by JFL Life Sciences was  XXXXXXXX, XXXXX XXXXX XXXXXX . JFL Life Sciences acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by JFL Life Sciences

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About JFL Life Sciences

When was JFL Life Sciences founded? JFL Life Sciences was founded in 2010.
Where is JFL Life Sciences headquartered? JFL Life Sciences is headquartered in India.
How many employees does JFL Life Sciences have? As of today, JFL Life Sciences has 39 employees.
Is JFL Life Sciences publicy listed? Yes, JFL Life Sciences is a public company listed on NSE.
What is the stock symbol of JFL Life Sciences? JFL Life Sciences trades under JFLLIFE ticker.
When did JFL Life Sciences go public? JFL Life Sciences went public in 2022.
Who are competitors of JFL Life Sciences? Similar companies to JFL Life Sciences include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of JFL Life Sciences? JFL Life Sciences's current market cap is $7.7M
What is the current revenue growth of JFL Life Sciences? JFL Life Sciences revenue growth between 2023 and 2024 was 9%.
Is JFL Life Sciences profitable? Yes, JFL Life Sciences is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.